A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: Vancomycin-resistant Enterococcus faecium

Microbial Drug Resistance

Volumn 12, Issue 1, 2006, Pages 59-62

  Baysallar, Mehmet ^a   Izci, Yusuf ^a   Kilic, Abdullah ^a   Avci, Ismail Yasar ^a   Senses, Zeynep ^a   Doganci, Levent ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; BRAIN VENTRICULITIS; CASE REPORT; CATHETER; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; DIFFUSION; DISK DIFFUSION METHOD; DRUG SUBSTITUTION; ENTEROCOCCUS FAECIUM; FEVER; HUMAN; HUMAN CELL; HYDROCEPHALUS; INFANT; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SHUNT INFECTION; SURGICAL DRAINAGE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CEREBROSPINAL FLUID; DRAINAGE; ENTEROCOCCUS FAECIUM; HUMANS; INFANT; MALE; VANCOMYCIN RESISTANCE; VENTRICULOPERITONEAL SHUNT;

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM;

EID: 33646054511     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.59     Document Type: Article

References (21)

1. Aryan, H.E., H.S. Meltzer, M.S. Park, R.L. Bennett, R. Jandial, and M.L. Levy. 2005. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv. Syst. 21:56-61.
2. Bayston, R., and E. Lambert. 1997. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J. Neurosurg. 87:247-251.
3. Choksey, M.S., and I.A. Malik. 2004. Zero tolerance to shunt infections: can it be achieved? J. Neurol. Neurosurg. Psychiatry 75:87-91.
4. Choux, M., L. Genitori, D. Lang, and G. Lena. 1992. Shunt implantation: reducing the incidence of shunt infection. J. Neurosurg. 77:875-880.
5. Gransden, W.R., A. King, D. Marossy, and E. Rosenthal. 1998. Quinupristin/dalfopristin in neonatal Enterococcus faecium meningitis. Arch. Dis. Child Fetal Neonatal. Ed. 78:235-236.
6. Hampl, J.A., A. Weitzel, J. Bonk, W. Kohnen, D. Roesner, and B. Jansen. 2003. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 31:109-111.
7. Kanchanapoom, T., J. Koirala, J. Goodrich, E. Agamah, and N. Khardori. 2003. Treatment of central nervous system infection by vancomycin-resistant Enterococcus faecium. Diagn. Microbiol. Infect. Dis. 45:213-215.
8. Kang, J.K., and I.W. Lee. 1999. Long-term follow-up of shunting therapy. Childs Nerv. Syst. 15:711-717.
9. Klekamp, J., D.M. Spengler, M.J. McNamara, and D.W. Haas. 1999. Risk factors associated with methicillin-resistant staphylococcal wound infection after spinal surgery. J. Spinal Disord. 12:187-191.
10. Kilic, A., T. Demiray, M.A. Saracli, G. Bahar, H. Aydogan, M. Baysallar, and L. Doganci. 2004. Bacteriological characterization of vancomycin-resistant enterococci in a pediatric hospital in Turkey. Ann. Microbiol. 54:543-551.
11. Levy, M.L., T. Luu, H.S. Meltzer, R. Bennett, and D.A. Bruce. 2004. Bacterial adhesion to surfactant-modified silicone surfaces. Neurosurgery 54:488-490; discussion 490-491.
12. Montero, A., J. Romero, J.A. Vargas, C.A. Regueiro, G. Sanchez-Alos, F. De Prados, A De la Torre, and G. Aragon. 2000. Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir. (Wien) 142:67-74.
13. Rice LB. 2001. Emergence of vancomycin-resistant enterococci. Emerg. Infect. Dis. 7:183-187.
14. Schierholz, J., B. Jansen, L. Jaenicke, and G. Pulverer. 1994. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 15:996-1000.
15. Schreffler, R.T., A.J. Schreffler, and R.R. Wittier. 2002. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr. Infect. Dis. J. 21:632-636.
16. Shaikh, Z.H., C.A. Peloquin, and C.D. Ericsson. 2001. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand. J. Infect. Dis. 33:375-379.
17. Takayama, Y., K. Sunakawa, and T. Akahoshi. 2003. Meningitis caused by Enterococcus gallinarum in patients with ventriculoperitoneal shunts. J. Infect. Chemother. 9:348-350.
18. Tan, T.Y., I. Pitman, A. Penrose-Stevens, B.A. Simpson, and P.G. Flanagan. 2000. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature. J. Infect. 41:95-97.
19. Tush, G.M., S. Huneycutt, A. Phillips, and J.D. Ward. 1998. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection. Clin. Infect. Dis. 26:1460-1461.
20. Zabramski, J.M., D. Whiting, R.O. Darouiche, T.G. Horner, J. Olson, C. Robertson, and A.J. Hamilton. 2003. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J. Neurosurg. 98:725-730.
21. Zeana, C., C.J. Kubin, P. Della-Latta, and S.M. Hammer. 2001. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin. Infect. Dis. 33:477-482.